- Advertisement -

CKT-UTAS launches disease awareness programme in Navrongo

- Advertisement -

C. K. Tedam University of Technology and Applied Sciences (CKT-UTAS) on Wednesday, March 30, 2022, launched a nationwide disease awareness programme aimed at raising awareness to support the early detection and diagnosis of Transthyretin (TTR) Amyloidosis in the country.

The initiative, according to the University, also supports needy families for early detection of the disease and treatment when necessary.

Speaking at the programme, the Vice-Chancellor of the University, Professor Eric Magnus Wilmot indicated that the programme goes beyond the borders of the region as it involves Public and Health Professionals Trainers and Trainees’ Perspectives.

He said, “… unfortunately our health care system has not been designed in any way to detect diseases of such nature early [Transthyretin (TTR) Amyloidosis]. But we are happy to have such a programme here at the University. It will help train health professionals and the public on early detection of it and how to diagnose and treat diseases of such nature when necessary.”

He also called on the principal researchers to be up and doing to be able to achieve the set goals.

“I think that a couple of years from now it should be possible for us to announce that we have overcome heart attack, issues of low blood pressure problems with the pumping of blood in the hearts and other parts of the body. This is a journey we are beginning and I am happy you all here will continue to stay with us till the end of the journey when we come back again to share some positive results”, he added.

The programme has its funding support from Global Bridges Amyloidosis at Mayo Clinic in the United States.

Amyloidosis refers to a disease caused by a buildup of abnormal proteins, called amyloid, in the body’s organs and peripheral nerves. These protein deposits can cause organs to not function properly and lead to nerve damage. Often, symptoms of amyloidosis are not specific or may seem similar to symptoms caused by other conditions.

ATTR amyloidosis is caused by a protein called transthyretin, or TTR, that changes its shape and forms into fibrous clumps. These clumps of misshapen protein are deposited into various organs and peripheral nerves, which can cause them to function abnormally.

A1radioonline.com|101.1 MHz|Moses Apiah|Bolgatanga|Ghana

- Advertisement -


- Advertisement -


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related news

- Advertisement -